Hopp til innhold

Get alerts of updates about «Antigen rapid test screening to prevent SARS-CoV-2 transmission at mass gathering events.»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel your alerts and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Antigen rapid test screening to prevent SARS-CoV-2 transmission at mass gathering events.

Project

Antigen rapid test screening to prevent SARS-CoV-2 transmission at mass gathering events. - project description

Published Updated

CANCELLED UNTIL FURTHER NOTICE To evaluate whether rapid testing is an effective intervention to prevent viral spread, comparative studies of rapid testing versus non-rapid testing are needed.


Summary

Using rapid tests for SARS-CoV-2 to screen participants before mass gathering events is a proposed strategy for conducting events at persistently high infection incidence. The tests' ability to detect infectious participants is uncertain since assessments of test properties (sensitivity / specificity) are based on comparisons with PCR test results. Although a PCR test is highly sensitivte with regard to the presence of virus particles, the test does not provide a clear answer as to whether a person is contagious, e.g. because those who have been infected may have positive test results also when they are no longer contagious. To evaluate whether rapid testing is an effective intervention to prevent viral spread, comparative studies of rapid testing versus non-rapid testing are needed. Randomisation of participants ensures comparable groups, enabling us to assess whether differences in infection levels are due to to differences exposure to the interventions (rapid tests and participation in events). The standard method for measuring COVID-19 prevalence in groups is to perform PCR testing of all participants, which is wha we plan to do.

See the full project description at Cristin for more information about results, researchers, contact information etc.

Project participants

Project leader

Atle Fretheim, Helsetjenester, Norwegian Institute of Public Health

Project participants

Atle Fretheim, Faculty of Health Sciences, Oslomet - Oslo Metropolitan University
Arnfinn Helleve, Psykisk og fysisk helse, Norwegian Institute of Public Health
Martin Flatø, Senter for fruktbarhet og helse, Norwegian Institute of Public Health
Tone Kristin Bjordal Johansen, Avdeling for smittevern og beredskap, Norwegian Institute of Public Health
Michael Bretthauer, Departement of Health Economics and Health Management, University of Oslo
Joakim Øverbø, Avdeling for smittevern og vaksine, Norwegian Institute of Public Health
Siri Laura Feruglio, Avdeling for smittevern og beredskap, Norwegian Institute of Public Health
Anne-Marte Bakken Kran, Avdeling for smittevernregistre, Norwegian Institute of Public Health

Start

05.05.2021

End

31.07.2021

Status

Active

Project owner/ Project manager

Norwegian Institute of Public Health

Project manager

Atle Fretheim